Target intelligence / Profile preview

RNA, U2 small nuclear 46, pseudogene (RNU2-46P)

Target: RNU2-46P
Molecular classification: Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene

Overview

RNA, U2 small nuclear 46, pseudogene (RNU2-46P) is classified as a **pseudogene** related to the U2 small nuclear RNA gene family; it is not known to encode a functional protein or RNA product and does not have therapeutic relevance as a biological target[1][2][3]. RNU2-46P is one of several non-coding RNA sequences that resemble U2 snRNA genes but are presumed functionless due to critical sequence mutations or loss of regulatory elements. No biological activity, drug interactions, or known disease relevance are associated with this gene.

Other names: RNU2-46PRNA, U2 small nuclear 46, pseudogene

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on RNA, U2 small nuclear 46, pseudogene (RNU2-46P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 46, pseudogene (RNU2-46P).

Explore the full profile